- Type / Class
- Equity / COM NEW
- Total 13F shares
- 20,022
- Share change
- +19,715
- Total reported value
- $57,942
- Price per share
- $2.87
- Number of holders
- 5
- Value change
- +$56,968
- Number of buys
- 4
- Number of sells
- 3
Quarterly Holders Quick Answers
What is CUSIP 45339J204?
CUSIP 45339J204 identifies INDP - Indaptus Therapeutics, Inc. - COM NEW in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45339J204:
Top shareholders of INDP - Indaptus Therapeutics, Inc. - COM NEW (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Glen R. Anderson |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,190,400
|
$2,785,536 | — | 10 Aug 2023 | |
| Hoonmo Lee |
3/4/5
|
Director |
—
mixed-class rows
|
708,272
mixed-class rows
|
$1,626,157 | — | 04 Aug 2021 | |
| Roger J. Waltzman |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
75,000
|
$5,325 | — | 09 Oct 2024 | |
| Boyan Vesselinov Litchev |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
1,150
|
$2,691 | — | 01 Feb 2022 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
—
class O/S missing
|
156
|
$1,643 | — | 30 Jun 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
—
class O/S missing
|
108
|
$1,137 | — | 30 Jun 2025 | |
| Brian O'Callaghan |
3/4/5
|
Director |
—
class O/S missing
|
13,750
|
$976 | — | 30 Sep 2022 | |
| Mark J. Gilbert |
3/4/5
|
Director |
—
class O/S missing
|
12,500
|
$888 | — | 10 Jun 2025 | |
| Robert Martell |
3/4/5
|
Director |
—
class O/S missing
|
12,500
|
$888 | — | 10 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
—
class O/S missing
|
31
|
$327 | — | 30 Jun 2025 | |
| FMR LLC |
13F
|
Company |
—
class O/S missing
|
10
|
$105 | — | 30 Jun 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
—
class O/S missing
|
2
|
$21 | — | 30 Jun 2025 | |
| Roger Pomerantz |
3/4/5
|
Director |
—
class O/S missing
|
30,000
|
— | — | 10 Jun 2025 | |
| Anthony J. Maddaluna |
3/4/5
|
Director |
—
class O/S missing
|
12,500
|
— | — | 10 Jun 2025 | |
| Hila Karah |
3/4/5
|
Director |
—
class O/S missing
|
12,500
|
— | — | 10 Jun 2025 | |
| William B. Hayes |
3/4/5
|
Director |
—
class O/S missing
|
12,500
|
— | — | 10 Jun 2025 |
Institutional Holders of Indaptus Therapeutics, Inc. - COM NEW (INDP) as of Q3 2025
As of 30 Sep 2025,
Indaptus Therapeutics, Inc. - COM NEW (INDP) was held by
5 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,022 shares.
The largest 5 holders included
Virtu Financial LLC, UBS Group AG, Tower Research Capital LLC (TRC), BANK OF AMERICA CORP /DE/, and SBI Securities Co., Ltd..
This page lists
5
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
5
Q3 2025 holders
5
Holder diff
0
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.